Granulocyte macrophage colony stimulating factor (GM-CSF) activity is regulated by a GM-CSF binding molecule in

Roni Mirski1, Fanny Reichert, Avihu Klar

  • 1Department of Anatomy and Cell Biology, Hebrew University-Hadassah Medical School, P.O.B. 12272, Jerusalem 91120, Israel.

Insights

Injury to peripheral nervous system (PNS) axons triggers the production of both GM-CSF inhibitor and augmenter activities during Wallerian degeneration. These activities are regulated, with augmentation at the onset and inhibition at later stages.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a key hematopoietic factor and inflammatory cytokine.
  • GM-CSF plays a crucial role in regulating macrophage and microglia function, impacting both peripheral nervous system (PNS) and central nervous system (CNS) injury and disease.

Purpose of the Study:

  • To investigate the regulation of GM-CSF activity following peripheral nervous system (PNS) axon injury.
  • To identify the presence and characteristics of GM-CSF-modulating activities during Wallerian degeneration (WD).

Main Methods:

  • Analysis of extracts and conditioned media (CM) from injured and intact PNS tissues.
  • Detection of GM-CSF inhibitor and augmenter activities in biological samples.
  • Utilized GM-CSF affinity chromatography to isolate and identify the inhibitor molecule.

Main Results:

  • PNS axon injury induces in vivo production of both GM-CSF-inhibitor and GM-CSF-augmenter activities.
  • GM-CSF-inhibitor activity was detected in injured PNS extracts and CM, but not in intact PNS.
  • A secreted GM-CSF binding molecule was identified as the carrier of the inhibitor activity.
  • CM exhibited both inhibitor and augmenter activities at different concentrations, with augmentation at lower and inhibition at higher levels.

Conclusions:

  • GM-CSF activity is dynamically regulated during Wallerian degeneration (WD).
  • Augmenter activity is associated with the early stages of WD, while inhibitor activity characterizes later stages.
  • These findings highlight a complex regulatory mechanism of GM-CSF during nerve injury and regeneration.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...